Bolt Biotherapeutics, Inc.
BOLT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$7,144 | -$8,561 | -$11,040 | -$15,936 |
| Dep. & Amort. | $290 | $347 | $399 | $426 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $625 | $709 | $1,182 |
| Change in WC | -$3,791 | -$2,462 | -$3,551 | -$1,196 |
| Other Non-Cash | $913 | $454 | $118 | $1,094 |
| Operating Cash Flow | -$9,732 | -$9,597 | -$13,365 | -$14,430 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$72 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $963 | $0 |
| Inv. Purchases | -$1,719 | -$14,465 | -$992 | -$13,253 |
| Inv. Sales/Matur. | $19,675 | $25,258 | $14,580 | $25,485 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $17,884 | $10,793 | $14,551 | $12,232 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $14 | $0 | $0 | $29 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$14 | $14 | $0 | $0 |
| Financing Cash Flow | $0 | $14 | $0 | $29 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $8,152 | $1,210 | $1,186 | -$2,169 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $10,385 | $10,156 | $8,970 | $11,139 |
| End Cash | $18,537 | $11,366 | $10,156 | $8,970 |
| Free Cash Flow | -$9,804 | -$9,597 | -$13,365 | -$14,430 |